Tracey Technologies
Tracey Technologies is a privately held Houston-based medical device company that designs and sells the iTrace, a 5-in-1 ophthalmic diagnostic workstation using patented ray tracing technology, primarily serving cataract and refractive surgeons globally via direct sales.
- Company typePrivate
- Founded1999
- HeadquartersHouston, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Tracey Technologies does
Tracey Technologies is a privately held US medical device company founded in 1999 and headquartered in Houston, Texas, that designs, manufactures, and sells the iTrace — a 5-in-1 ophthalmic diagnostic workstation combining wavefront aberrometry, corneal topography, autorefraction, keratometry, and pupillometry in a single device. Its core technical differentiator is a patented ray tracing wavefront sensor that projects 256 parallel light rays through the pupil entrance and measures each ray's retinal landing position, enabling the device to mathematically separate corneal from internal optical contributions to vision loss — a capability the company states competitors using Hartmann-Shack sensors cannot replicate, particularly in highly aberrated eyes or through implanted/ocular-surface-compromised lenses. Layered on this sensor are proprietary 0–10 clinical indices (Dysfunctional Lens Index, Corneal Performance Index, Quality of Vision Index, Tear Film Index) plus surgical planning modules (Toric Planner, Toric Check) that the company markets primarily to cataract and refractive surgeons for premium IOL selection, toric IOL alignment, and post-operative verification.
The company monetizes primarily through one-time hardware sales of the iTrace device on a quote-based motion, supplemented by downloadable paid software upgrades (most recently iTrace Prime v7.0 in 2023), on-site and remote training, and ongoing customer support. It serves a global installed base of ophthalmologists and optometrists across the United States, Europe, Canada, Latin America, India, the Middle East, Russia, and Southern Africa, sold through a wholly direct sales organization of regional managers rather than a distributor network. The company is founder-controlled (CEO Joe Wakil, who also founded EyeSys Technologies, the firm credited with pioneering commercial corneal topography) and has not disclosed institutional funding, M&A, or leadership transitions.
Tracey Technologies firmographics
Firmographics- Name
- Tracey Technologies
- Legal name
- Tracey Technologies Corporation
- Website
- https://traceytechnologies.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Tracey Technologies is a privately held Houston-based medical device company that designs and sells the iTrace, a 5-in-1 ophthalmic diagnostic workstation using patented ray tracing technology, primarily serving cataract and refractive surgeons globally via direct sales.
- Ownership category
- akta.pro rank
Tracey Technologies industry classification
Industry- Product category
- Ophthalmic Diagnostic Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Ophthalmic Goods Manufacturing (339115)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Refractive Diagnostics & Biometry (Autorefractors, Keratometers, Topography/Tomography, A-Scan/Optical Biometry) (HLAHAJAA)
- akta.pro secondary industries
- Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH), Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF)
Keywords
Where Tracey Technologies is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Tracey Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- iTrace Device Sales: Primary revenue from sale of the iTrace ophthalmic diagnostic device. The device combines wavefront aberrometry, corneal topography, autorefraction, keratometry, and pupillometry in a single piece of equipment for ophthalmic practices.
- Software Upgrades: Revenue from software upgrades (e.g., Version 7.0 iTrace Prime) that can be downloaded on existing hardware, providing new features and capabilities.
- Customer Support & Training: Ongoing support services including on-site and remote training, software activation, and technical support for existing iTrace users.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | iTrace Device - Base Configuration |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
Tracey Technologies product offering
Product offeringCore offering
Tracey Technologies manufactures and sells the iTrace, a 5-in-1 ophthalmic diagnostic device that combines a wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer in a single unit. The device uses patented ray tracing technology (256 parallel light rays projected through the pupil) to objectively separate corneal from internal optical performance, and is sold with proprietary software (currently iTrace Prime / Version 7.0) that delivers diagnostic indices (DLI, CPI, QVI, TFI) and Toric Planner/Check surgical planning tools. The product is sold directly to ophthalmologists, cataract and refractive surgeons, and optometrists worldwide, supported by downloadable software upgrades and on-site or remote training.
Product overview
Tracey Technologies offers the iTrace as its core product — a unified ophthalmic diagnostic platform that combines 5 devices in 1 (wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer). The hardware platform is upgraded through software versions, with iTrace Prime (Version 7.0) being the latest. Key proprietary metrics include the Dysfunctional Lens Index (DLI), Corneal Performance Index (CPI), Quality of Vision Index (QVI), and Tear Film Index (TFI), all displayed on 0-10 scales for clinical decision-making. Surgical planning features include Toric Planner for pre-operative calculations and Toric Check for post-operative verification without dilation. The system enables separation of corneal from internal optical performance, making it unique for premium IOL selection and cataract surgery planning.
Differentiator
Problem solved
Functional benefit
Brands
- iTrace: The flagship 5-in-1 ophthalmic device combining wavefront aberrometry, corneal topography, autorefraction, keratometry, and pupillometry using proprietary ray-tracing technology.
- iTrace Prime
Products and services
- iTrace Device 5-in-1 ophthalmic diagnostic device combining wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer in a single unit. Uses patented ray tracing technology to send 256 parallel light rays through the eye for objective measurement, sold to ophthalmologists, cataract and refractive surgeons, and optometrists.
- iTrace Prime Software (Version 7.0) Latest software platform for the iTrace device featuring the Prime Dashboard, Tear Film Index, improved imaging quality, and enhanced surgical planning tools. Sold as a downloadable upgrade that adds new capabilities to existing iTrace hardware.
Quantifiable outcome
- 40% premium IOL conversion rate achieved by Dr. Garg (up from 5% prior to iTrace adoption)
- +4 more outcomes
Companies that use Tracey Technologies
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles1 record
Tracey Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature8 records
Tracey Technologies partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights6 records
Tracey Technologies competitors and assessment
Company assessmentBroad incumbents
- Topcon Healthcare: Topcon offers a broad portfolio of ophthalmic diagnostic instruments (refraction, OCT, corneal mapping, perimetry) used in optometry and ophthalmology practices worldwide. Topcon's multi-modality diagnostic platforms compete with iTrace for clinical budget and workflow integration, particularly in optometric referral practices.
- Alcon: Alcon is a global leader in cataract surgical devices and premium IOLs (PanOptix, Vivity) following its acquisition of WaveLight and other diagnostic assets. As a buyer of premium IOLs, Alcon's equipment partners and bundled diagnostic solutions compete with the iTrace in the same ophthalmic surgical suite.
- Heidelberg Engineering: Heidelberg Engineering is an incumbent in ophthalmic imaging, particularly spectral-domain OCT platforms (Heidelberg Retina Tomograph) used by ophthalmologists. The company acquired Oculus and now competes broadly with Tracey across anterior and posterior segment diagnostics, with greater R&D scale and global distribution.
- Carl Zeiss Meditec: Carl Zeiss Meditec is a leading global ophthalmic medical technology company spanning cataract surgical devices, IOLs, OCT imaging, and refractive diagnostics. While broader than Tracey, Zeiss competes for the same ophthalmic capital budgets and increasingly bundles diagnostic platforms (e.g., IOLMaster biometry) that overlap with iTrace workflow integration.
- Bausch + Lomb (BVI Medical): Bausch + Lomb / BVI is a major player in cataract surgical instruments and intraocular lenses (e.g., enVista, LuxSmart). While primarily a surgical/IOL company, its diagnostic partnerships and bundled offerings (e.g., with IOL biometry and surgical planning) overlap with the iTrace's pre-operative IOL selection workflow.
Direct peers
- Oculus (Pentacam): OCULUS Pentacam is a leading corneal topography and tomography platform competing for the same diagnostic cabinet in refractive and cataract practices. Tracey markets directly against Pentacam on its website, indicating they compete for the same budget, same workflow, and same surgical planning use cases — particularly cataract/IOL and refractive surgery pre-operative assessment.
- Marco (I·O·M): Marco's OPD III is a 5-in-1 wavefront aberrometer/topographer/autorefractor/keratometer/pupillometer — essentially the direct head-to-head competitor to the iTrace. Tracey features an explicit "iTrace vs Marco OPD" comparison page, confirming identical clinical use cases (cataract and refractive pre-op planning, IOL selection) and target customers (ophthalmologists and optometrists).
- Nidek: Nidek's OPD-Scan III is a wavefront aberrometer that competes directly with the iTrace in cataract and refractive surgery workups across global ophthalmic markets. Both devices target ophthalmologists and optometrists performing objective refraction, corneal topography, and IOL power calculations using comparable technical approaches.
Emerging players
- Costruzione Strumenti Oftalmici (CSO): CSO is an Italian ophthalmic equipment manufacturer specializing in corneal topography, aberrometry, and biometry devices sold to ophthalmic clinics worldwide. As a smaller but technically focused player, CSO competes with the iTrace on specific corneal topography and wavefront functions in regional markets.
- Ziemer Ophthalmology: Ziemer specializes in femtosecond laser cataract surgery systems and diagnostic imaging devices for ophthalmology. It is smaller than the broad incumbents but competes in the premium cataract surgical workflow that the iTrace is increasingly integrated with, particularly in markets deploying femto-cataract platforms.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Tracey Technologies social profiles
Digital presenceTracey Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tracey Technologies leadership team
Management profileNumber of profiles
Profiles8 records
Tracey Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tracey Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tracey Technologies
What does Tracey Technologies do?
Tracey Technologies manufactures and sells the iTrace, a 5-in-1 ophthalmic diagnostic device that combines a wavefront aberrometer, corneal topographer, autorefractor, keratometer, and pupillometer in a single unit. The device uses patented ray tracing technology (256 parallel light rays projected through the pupil) to objectively separate corneal from internal optical performance, and is sold with proprietary software (currently iTrace Prime / Version 7.0) that delivers diagnostic indices (DLI, CPI, QVI, TFI) and Toric Planner/Check surgical planning tools. The product is sold directly to ophthalmologists, cataract and refractive surgeons, and optometrists worldwide, supported by downloadable software upgrades and on-site or remote training.
Is Tracey Technologies a public or private company?
Tracey Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Tracey Technologies founded?
Tracey Technologies was founded in 1999. It employs 11 to 50 people.
Where is Tracey Technologies based?
Tracey Technologies is headquartered in Houston, United States, in the North America region.
How does Tracey Technologies make money?
Three revenue lines are on record. iTrace Device Sales are the primary driver. The others are software Upgrades and customer Support & Training.
Who are Tracey Technologies's main competitors?
Broad incumbents on record are Topcon Healthcare, Alcon, Heidelberg Engineering, Carl Zeiss Meditec and Bausch + Lomb (BVI Medical). Direct peers are Oculus (Pentacam), Marco (I·O·M) and Nidek. Emerging players are Costruzione Strumenti Oftalmici (CSO) and Ziemer Ophthalmology.
Does Tracey Technologies have an API?
No public API is recorded for Tracey Technologies.
What industry is Tracey Technologies in?
Tracey Technologies's product category is Ophthalmic Diagnostic Equipment. Its primary akta.pro industry code is HLAHAJAA, Refractive Diagnostics & Biometry (Autorefractors, Keratometers, Topography/Tomography, A-Scan/Optical Biometry), with a secondary code of HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics). Its NAICS code is 334510 and its SIC code is 3841.